Soleno Therapeutics (SLNO) Intangibles: 2015-2019
Historic Intangibles for Soleno Therapeutics (SLNO) over the last 5 years, with Sep 2019 value amounting to $17.0 million.
- Soleno Therapeutics' Intangibles fell 10.26% to $17.0 million in Q3 2019 from the same period last year, while for Sep 2019 it was $17.0 million, marking a year-over-year decrease of 10.26%. This contributed to the annual value of $18.5 million for FY2018, which is 9.52% down from last year.
- Per Soleno Therapeutics' latest filing, its Intangibles stood at $17.0 million for Q3 2019, which was down 2.78% from $17.5 million recorded in Q2 2019.
- In the past 5 years, Soleno Therapeutics' Intangibles registered a high of $21.1 million during Q1 2017, and its lowest value of $76,340 during Q4 2015.
- Over the past 3 years, Soleno Therapeutics' median Intangibles value was $19.4 million (recorded in 2017), while the average stood at $19.1 million.
- As far as peak fluctuations go, Soleno Therapeutics' Intangibles dropped by 10.99% in 2016, and later soared by 2,268.61% in 2017.
- Quarterly analysis of 5 years shows Soleno Therapeutics' Intangibles stood at $76,340 in 2015, then declined by 10.99% to $842,000 in 2016, then surged by 2,198.46% to $20.4 million in 2017, then declined by 9.52% to $18.5 million in 2018, then dropped by 10.26% to $17.0 million in 2019.
- Its Intangibles was $17.0 million in Q3 2019, compared to $17.5 million in Q2 2019 and $18.0 million in Q1 2019.